ArticleBrain and behavior2025
Towards Clinical Diagnoses: Classifying Alzheimer's Disease Using Single fMRI, Small Datasets, and Transfer Learning.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Functional and Clinical: An Explainable Deep Learning Model for Multimodal Alzheimer's Disease Classification.Brain and behavior · 2026Article
- Leveraging AI-Driven Neuroimaging Biomarkers for Early Detection and Social Function Prediction in Autism Spectrum Disorders: A Systematic Review.Healthcare (Basel, Switzerland) · 2025Review
- Gender-based Alzheimer's detection using ResNet-50 and binary dragonfly algorithm on neuroimaging.Frontiers in artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeDeep learning and functional magnetic resonance imaging (fMRI) are two unique methodologies that can be combined to diagnose Alzheimer's disease (AD). Multiple studies have harnessed these methods to diagnose AD with high accuracy. However, there are difficulties in adapting this research to real-world diagnoses. For example, the two key issues of data availability and model usability limit clinical applications. These two areas are concerned with problems of accessibility, generalizability, and methodology that may limit model adoption. For example, fMRI deep learning models require a large amount of training data, which is not widely available. Contemporary models are also not typically formatted for clinical data or created for use by non-specialized populations. In this study, we develop a deep-learning fMRI pipeline that addresses some of these issues.
methodWe use transfer learning to address problems with data availability. We also use semi-automated and single-image techniques (i.e., one fMRI volume per participant) to make a model that is usable for non-specialized populations. Our model was initially trained on 524 participants from the Autism Brain Imaging Data Exchange (ABIDE; Autism and controls). Our model was then transferred and fine-tuned to a small sample of 64 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; AD and controls). FINDINGS AND
conclusionThis transfer learning model achieved an AD classification accuracy of 77% and outperformed the same model without transfer learning by approximately 30%. Accordingly, our model showed that small AD samples can be accurately classified in a clinically friendly manner.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.